Research output per year
Research output per year
Personal profile
Expertises
heart failure, atrial fibrillation; oral anticoagulation; antiplatelet; NOAC; non-vitamin K antagonist oral anticoagulation; antithrombotics, coronary artery disease; sleep apnea; non-steroidal anti-inflammatory drugs; proton-pump inhibitors; bleeding; epidemiology; pharmacoepidemiology, pharmacotherapy; data management
Main research areas
heart failure, atrial fibrillation; oral anticoagulation; antiplatelet; NOAC; non-vitamin K antagonist oral anticoagulation; antithrombotics, coronary artery disease; sleep apnea; non-steroidal anti-inflammatory drugs; proton-pump inhibitors; bleeding; epidemiology; pharmacoepidemiology, pharmacotherapy
Current research
Heart failure and sleep apnea
Cancer and cardiovascular disease
Antithrombotic treatment in atrial fibrillation
Fingerprint
Dive into the research topics where Morten Lamberts is active. These topic labels come from the works of this person. Together they form a unique fingerprint.
- 1 Similar Profiles
Network
Recent external collaboration on country/territory level. Dive into details by clicking on the dots or
-
Prognosis of acute coronary syndrome stratified by cancer type and status -A nationwide cohort study
Nouhravesh, N., Strange, J. E., Tønnesen, J., Holt, A., Andersen, C. F., Jensen, M. H., Al-Alak, A., D'Souza, M., Nielsen, D., Kragholm, K., Fosbøl, E. L., Schou, M. & Lamberts, M. K., Feb 2023, In: American Heart Journal. 256, p. 13-24 12 p.Research output: Contribution to journal › Journal article › Research › peer-review
-
Adverse Events Associated With Coprescription of Phosphodiesterase Type 5 Inhibitors and Oral Organic Nitrates in Male Patients With Ischemic Heart Disease: A Case-Crossover Study
Holt, A., Blanche, P., Jensen, A. K. G., Nouhravesh, N., Rajan, D., Jensen, M. H., El-Sheikh, M., Schjerning, A-M., Schou, M., Gislason, G., Torp-Pedersen, C., McGettigan, P. & Lamberts, M., Jun 2022, In: Annals of Internal Medicine. 175, 6, p. 774-782 9 p.Research output: Contribution to journal › Journal article › Research › peer-review
-
Bleeding risk following systemic fluconazole or topical azoles in patients with atrial fibrillation on apixaban, rivaroxaban or dabigatran
Holt, A., Strange, J. E., Rasmussen, P. V., Blanche, P., Nouhravesh, N., Jensen, M. H., Schjerning, A-M., Schou, M., Torp-Pedersen, C., Gislason, G. H., Hansen, M. L., McGettigan, P. & Lamberts, M., May 2022, In: American Journal of Medicine. 135, 5, p. 595-602.e5Research output: Contribution to journal › Journal article › Research › peer-review
4 Citations (Scopus) -
Clinical cardiovascular phenotypes and the pattern of future events in patients with type 2 diabetes
Malik, M. E., Andersson, C., Blanche, P., D'Souza, M., Madelaire, C., Zareini, B., Lamberts, M., Kristensen, S. L., Sattar, N., McMurray, J., Køber, L., Torp-Pedersen, C., Gislason, G. & Schou, M., 8 Apr 2022, (E-pub ahead of print) In: Clinical research in cardiology : official journal of the German Cardiac Society.Research output: Contribution to journal › Journal article › Research › peer-review
-
Gastrointestinal bleeding risk following concomitant treatment with oral glucocorticoids in patients on non-vitamin K oral anticoagulants
Holt, A., Blanche, P., Zareini, B., Rasmussen, P. V., Strange, J. E., Rajan, D., Jensen, M. H., El-Sheikh, M., Schjerning, A-M., Schou, M., Gislason, G., Torp-Pedersen, C., McGettigan, P. & Lamberts, M., Apr 2022, In: Heart (British Cardiac Society). 108, 8, p. 626-632 7 p.Research output: Contribution to journal › Journal article › Research › peer-review